Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Additional Paid-In Capital	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		656,872,000
Beginning balance at Dec. 31, 2021	$ 3,038,743	$ 7	$ 5,059,528	$ (2,181)	$ (2,018,611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Release of restricted stock units and issuance of restricted stock awards (in shares)		5,013,000
Issuance of common stock for cash upon exercise of stock options, net (in shares)		369,000
Issuance of common stock for cash upon exercise of stock options, net	1,036		1,036
Share-based compensation	73,240		73,240
Other comprehensive income (loss)	(8,078)			(8,078)
Net loss	(5,281)				(5,281)
Ending balance (in shares) at Mar. 31, 2022		662,254,000
Ending balance at Mar. 31, 2022	3,099,660	$ 7	5,133,804	(10,259)	(2,023,892)
Beginning balance (in shares) at Dec. 31, 2022		683,202,000
Beginning balance at Dec. 31, 2022	3,281,654	$ 7	5,407,724	(11,419)	(2,114,658)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Release of restricted stock units and issuance of restricted stock awards (in shares)		2,775,000
Shares repurchased for tax withholdings on release of restricted stock units and restricted stock awards	$ (91,508)		(91,508)
Issuance of common stock for cash upon exercise of stock options, net (in shares)	950,000	950,000
Issuance of common stock for cash upon exercise of stock options, net	$ 2,400		2,400
Repurchases of Class A common stock (in shares)	(2,769,740)	(2,770,000)
Repurchases of Class A common stock	$ (71,637)		(71,637)
Share-based compensation	143,122		143,122
Other comprehensive income (loss)	4,287			4,287
Net loss	(208,579)				(208,579)
Ending balance (in shares) at Mar. 31, 2023		684,157,000
Ending balance at Mar. 31, 2023	$ 3,059,739	$ 7	$ 5,390,101	$ (7,132)	$ (2,323,237)